"Hematopoietic Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Descriptor ID |
D018380
|
MeSH Number(s) |
E02.095.147.500.500.500 E04.936.225.687.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Transplantation".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Transplantation" by people in this website by year, and whether "Hematopoietic Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 3 | 2 | 5 |
2013 | 2 | 0 | 2 |
2014 | 1 | 2 | 3 |
2015 | 0 | 1 | 1 |
2017 | 0 | 2 | 2 |
2018 | 1 | 3 | 4 |
2019 | 2 | 3 | 5 |
2020 | 1 | 0 | 1 |
2021 | 3 | 0 | 3 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Transplantation" by people in Profiles.
-
DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation. Blood Cancer J. 2023 05 10; 13(1):73.
-
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial. Pediatr Blood Cancer. 2022 12; 69(12):e29997.
-
Successful allogeneic stem cell transplantation of a patient with Werner syndrome and acute myeloid leukemia. Leuk Res. 2021 09; 108:106609.
-
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021 07; 56(7):1723-1727.
-
Endothelium-derived stromal cells contribute to hematopoietic bone marrow niche formation. Cell Stem Cell. 2021 04 01; 28(4):653-670.e11.
-
Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia. Am J Hematol. 2021 01; 96(1):E15-E17.
-
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo. Leukemia. 2020 03; 34(3):771-786.
-
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics. J Clin Oncol. 2019 12 20; 37(36):3493-3506.
-
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets. Blood Adv. 2019 10 22; 3(20):3143-3156.
-
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL. Bone Marrow Transplant. 2019 11; 54(11):1847-1858.